白藜芦醇对多囊卵巢综合征的影响:一项双盲、随机、安慰剂对照试验
该随机双盲安慰剂对照试验纳入34例多囊卵巢综合征(PCOS)受试者,30例完成3个月试验,每日口服白藜芦醇1500 mg或安慰剂。白藜芦醇使血清总睾酮降低23.1%(P=0.01),硫酸脱氢表雄酮降低22.2%(P=0.01),空腹胰岛素降低31.8%(P=0.007),胰岛素敏感性指数升高66.3%(P=0.04);促性腺激素、血脂谱及炎症和内皮功能标志物无显著改变。
要点
- 白藜芦醇使PCOS患者血清总睾酮降低23.1%(P=0.01)。
- 白藜芦醇使硫酸脱氢表雄酮降低22.2%(P=0.01),空腹胰岛素降低31.8%(P=0.007)。
- 白藜芦醇使胰岛素敏感性指数(Matsuda和DeFronzo)升高66.3%(P=0.04)。
核心结论
- 白藜芦醇显著降低卵巢和肾上腺雄激素。
- 该效应可能至少部分与胰岛素敏感性改善和胰岛素水平下降有关。
研究设计与样本
- 随机(1:1)双盲安慰剂对照试验,在学术医院评估白藜芦醇为期3个月的效果。
- 按Rotterdam标准识别PCOS受试者,纳入34例,30例完成试验。
- 干预为每日口服白藜芦醇1500 mg或安慰剂,基线和治疗3个月后进行评估。
主要发现
- 白藜芦醇使血清总睾酮降低23.1%(P=0.01)。
- 白藜芦醇使硫酸脱氢表雄酮降低22.2%(P=0.01)。
- 白藜芦醇使空腹胰岛素降低31.8%(P=0.007)。
- 白藜芦醇使胰岛素敏感性指数(Matsuda和DeFronzo)升高66.3%(P=0.04)。
- 促性腺激素、血脂谱以及炎症和内皮功能标志物无显著改变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age. Hyperandrogenism is the central feature of PCOS. Studies on isolated ovarian theca-interstitial cells suggest that resveratrol, a natural polyphenol, reduces androgen production. OBJECTIVE: This study was designed to evaluate endocrine and metabolic effects of resveratrol on PCOS. DESIGN AND SETTING: This was a randomized (1:1) double-blind, placebo-controlled trial that evaluated the effects of resveratrol over a period of 3 months in an academic hospital. PATIENTS AND OTHER PARTICIPANTS: Subjects with PCOS were identified according to the Rotterdam criteria. Thirty-four subjects were enrolled and 30 subjects completed the trial. Evaluations were performed at baseline and repeated after 3 months of treatment. INTERVENTION: Resveratrol (1,500 mg p.o.) or placebo were administered daily. MAIN OUTCOME MEASURE: Primary outcome was the change in the serum total T. RESULTS: Resveratrol treatment led to a significant decrease of total T by 23.1% (P = .01). In parallel, resveratrol induced a 22.2% decrease of dehydroepiandrosterone sulfate (P = .01), a decrease of fasting insulin level by 31.8% (P = .007) and an increase of the Insulin Sensitivity Index (Matsuda and DeFronzo) by 66.3% (P = .04). Levels of gonadotropins, the lipid profile as well as markers of inflammation and endothelial function were not significantly altered. CONCLUSIONS: Resveratrol significantly reduced ovarian and adrenal androgens. This effect may be, at least in part, related to an improvement of insulin sensitivity and a decline of insulin level.
引用
- Banaszewska B, Wrotyńska-Barczyńska J, Spaczynski RZ, et al. Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial. J Clin Endocrinol Metab. 2016. PMID: 27754722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。